Abstract
The spectrum of diagnostic procedures for clinically defining the extent of incidentally discovered carcinoma of the prostate depends to a considerable degree on the individual treatment philosophy. For proponents of a more aggressive management who consider even patients with D1 lesions as candidates for radical surgery, staging efforts may be restricted to the exclusion of distant lesions. Those who favor a rather conservative line may need more information to exclude progressive disease particularly if immediate androgen deprivation would be initiated in this situation. It is obvious that there is no undisputed, simple, efficient, and cost-saving recommendation as to which diagnostic measures are to be applied.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Benson KH, Watson RA, Spring DB, Agee RE (1981) The value of computerized tomography in evaluation of pelvic lymph nodes. J Urol 126:63–64
Brendler CB, Cleeve LK, Anderson EE, Paulson DF (1980) Staging pelvic lymphadenectomy for carcinoma of the prostate: risk versus benefit. J Urol 124:849–850
Bruce AW, O’Cleireachain F, Morales A, Awad SA (1977) Carcinoma of the prostate: a critical look at staging. J Urol 117:319–322
Donohue RE, Mani JH, Whitesel JA, Mohr S, Scanavino D, Augspurger RR, Biber RJ, Fauver HE, Wettlaufer JN, Pfister R (1982) Pelvic lymph node dissection. Urology 20:559–565
Fowler JE Jr, Torgerson L, McLeod DG, Stutzman RE (1981) Radical prostatectomy with pelvic lymphadenectomy: observations on the accuracy of staging with lymph node frozen sections. J Urol 126:618–619
Freiha FS, Pistenma DA, Bagshaw MA (1979) Pelvic lymphadenectomy for staging prostatic carcinoma: Is it always necessary? J Urol 122:176–177
Golimbu M, Schinella R, Morales P, Kurusu S (1978) Differences in pathological characteristics and prognosis of clinical A2 prostatic cancer from A1 and B disease. J Urol 119:618–622
Golimbu M, Morales P, Al-Askari S, Brown J. (1979) Extended pelvic lymphadenectomy for prostatic cancer. J Urol 121:617–620
Grossman IC, Carpiniello V, Greenberg SH, Malloy TR, Wein AJ (1980) Staging pelvic lymphadenectomy for carcinoma of the prostate. Review of 91 cases. J Urol 124:632–634
Levine MS, Arger PH, Coleman BG, Mulhern CB Jr, Pollack HM, Wein A-J (1981) Detecting lymphatic metastases from prostatic carcinoma: superiority of CT. AJR 137:207–211
Lieskovsky G, Skinner DG, Weisenburger T (1980) Pelvic lymphadenectomy in the management of carcinoma of the prostate. J Urol 124:635–638
Lytton B, Collins JT, Weiss RM, Schiff M Jr, McGuire EJ, Livolsi V (1979) Results of biopsy after early stage prostatic cancer treatment by implantation of 125I seeds. J Urol 121:306–309
McLaughlin AP, Saltzstein SL, McCullough DL, Gittes RF (1976) Prostatic carcinoma: incidence and location of unsuspected lymphatic metastases. J Urol 115:89–94
Middleton R (1978) Pelvic lymphadenectomy: recent results. Annual Meeting, American Urological Association, 21 May 1978
Nicholson TC, Richie JP (1977) Pelvic lymphadenectomy for stage B1 adenocarcinoma of the prostate: justified or not? J Urol 117:199–201
Paulson DF, Uro-Oncology Research Group (1979) The impact of current staging procedures in assessing disease extent of prostatic adenocarcinoma. J Urol 121:300–302
Prout GR Jr, Heaney JA, Griffin PP, Daly JJ, Shipley WU (1980) Nodal involvement as a prognostic indicator in patients with prostatic carcinoma. J Urol 124:226–231
Schaffer DL, Pendergrass HP (1976) Comparison of enzyme, clinical radiographic and radionuclide methods of detecting bone metastases from carcinoma of the prostate. Radiology 121:431–434
Stamey TA, Kabalin JN (1989) Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients. J Urol 141:1070–1075
Weinerman PM, Arger PH, Coleman BG, Pollack HM, Banner MP, Wein AJ (1983) Pelvic adenopathy from bladder and prostate carcinoma: detection by rapid sequence tomography. AJR 140:95–99
Whitehead ED, Huh SH, Garcia RL, Rao R, Leiter E (1981) Interstitial irradiation of carcinoma of the prostate with 125iodine and simultaneous extraperitoneal pelvic lymphadenectomy in 32 patients: trials, tribulations and possible triumphs. J Urol 126:366–371
Zincke H, Farrow GM, Myers RP, Benson RC Jr, Furlow WL, Utz DC (1982) Relationship between grade and stage of adenocarcinoma of the prostate and regional pelvic lymph node metastases. J Urol 128:498–501
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Ackermann, R. (1991). Staging Extent in Incidental Carcinoma of the Prostate: Efficacy Versus Economy. In: Altwein, J.E., Faul, P., Schneider, W. (eds) Incidental Carcinoma of the Prostate. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76129-4_22
Download citation
DOI: https://doi.org/10.1007/978-3-642-76129-4_22
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-76131-7
Online ISBN: 978-3-642-76129-4
eBook Packages: Springer Book Archive